- we maintain a broad portfolio, with a particular interest in respiratory disease, infections and antibiotic resistance, liver disease, cardiovascular disease, primary care and herbal treatments
- we can develop and conduct a broad range of trials, from drug trials and complex interventions, through to symptom control and digital technologies
- we are closely linked with the NIHR BOB体育登录网址_欧宝体育官网平台-APP|下载 Biomedical Research Centre, where our Director is a co-investigator on the respiratory theme
- our team has expertise in trial methodology and qualitative research with the aim of improving trial design and research outcomes for the research community, trial participants and healthcare providers
BOB体育登录网址_欧宝体育官网平台-APP|下载 statisticians are at the forefront of innovative trial development, such as the use of adaptive Bayesian designs for phase I dose-finding studies, as used in the AGILE BOB体育登录网址_欧宝体育官网平台-APP|下载 platform.